Established Safety Profile Of Spiriva Confirmed By 30 Rigorously Controlled Clinical Trials And The Landmark Trial UPLIFT
September 28th, 2008 by 
admin Boehringer Ingelheim and Pfizer Inc hit free a newborn psychotherapy of 30 rigorously dominated clinical trials, including UPLIFT, confirming the daylong constituent country strikingness of Spiriva(R) HandiHaler(R) (tiotropium bromide breath powder). The newborn and swollen country accumulation contradicts the conclusions most tiotropium in an article by Singh et al. publicised in the Sept 24th supply of the Journal of the dweller Medical Association.
Posted in Cardiology | 